Latest news
Evolus expands strategic partnership with Symatese to commercialize Estyme - TipRanksTipRanks · Tue, 04 Aug 2026 17:50:21 GMTEvolus Expands Estyme Aesthetic Portfolio into New Markets - TipRanksTipRanks · Tue, 04 Aug 2026 13:56:20 GMTEvolus, Inc. (NASDAQ: EOLS) extends Estyme deal to $500M markets - Stock TitanStock Titan · Tue, 04 Aug 2026 12:46:29 GMTEvolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:30:00 GMT